Holen Sie sich die Stockscreener-App
60.52
3.91%
2.275
Vorhandelsmarkt:
58.08
-2.44
-4.03%
Schlusskurs vom Vortag:
$58.24
Offen:
$58.5
24-Stunden-Volumen:
471.69K
Relative Volume:
1.48
Marktkapitalisierung:
$1.80B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-16.49
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
+4.65%
1M Leistung:
-6.17%
6M Leistung:
+33.30%
1J Leistung:
-6.47%
1-Tages-Spanne:
$58.49
$62.02
1-Wochen-Bereich:
$58.06
$62.02
52-Wochen-Spanne:
$25.60
$77.60
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
60.52 | 1.80B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Cantor Fitzgerald Estimates Disc Medicine FY2025 Earnings - MarketBeat
Disc Medicine: Potential Promise Amid Uncertainty (NASDAQ:IRON) - Seeking Alpha
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine Announces $200M Public Offering to Advance EPP Treatment Pipeline - StockTitan
HC Wainwright Reiterates "Buy" Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat
Disc Medicine's (IRON) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Disc Medicine Announces Successful Type C Meeting with FDA - GlobeNewswire
Disc Medicine Secures FDA Fast-Track Path for Groundbreaking EPP Treatment Bitopertin - StockTitan
Disc Medicine to Host FDA Meeting Update Call on Bitopertin EPP Treatment Progress - StockTitan
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewswire
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Up 6.6% in December - MarketBeat
Exciting News From a Fast-Growing Biopharma! New Employee Benefits Unveiled! - Zaman
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Disc Medicine Grants New Employee 58,333 Share Equity Inducement Award - StockTitan
Disc Medicine's SWOT analysis: rare blood disorder stock shows promise - Investing.com India
How the (IRON) price action is used to our Advantage - Stock Traders Daily
Wedbush Reiterates Outperform Rating for Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Earns "Outperform" Rating from Wedbush - MarketBeat
Disc Medicine Highlights 2025 Strategy and Financial Updates - TipRanks
Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025 - The Manila Times
Disc Medicine Highlights Recent Achievements Across - GlobeNewswire
Disc Medicine Advances EPP Treatment: FDA Fast-Track Talks & $178M Funding Boost Clinical Pipeline - StockTitan
Disc medicine chief legal officer sells $470,657 in stock By Investing.com - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells $470,625.00 in Stock - MarketBeat
Disc medicine chief legal officer sells $470,657 in stock - Investing.com India
When (IRON) Moves Investors should Listen - Stock Traders Daily
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
John D. Quisel Sells 13,012 Shares of Disc Medicine, Inc. (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine CEO sells over $806,000 in stock By Investing.com - Investing.com Nigeria
Disc Medicine CEO sells over $806,000 in stock - Investing.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Could Be 29% Below Their Intrinsic Value Estimate - Simply Wall St
Stifel Financial Corp Cuts Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Jane Street Group LLC Trims Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Geode Capital Management LLC Purchases 70,983 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Geode Capital Management LLC Buys 70,983 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Barclays PLC Has $1.97 Million Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Barclays PLC - MarketBeat
Disc Medicine CEO John Quisel sells $1.25 million in stock By Investing.com - Investing.com Australia
Disc Medicine CEO John Quisel sells $1.25 million in stock - Investing.com India
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $1,251,434.80 in Stock - MarketBeat
(IRON) On The My Stocks Page - Stock Traders Daily
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by State Street Corp - Defense World
State Street Corp Boosts Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Disc Medicine (NASDAQ:IRON) Stock Price Down 3%Should You Sell? - MarketBeat
Disc medicine CEO sells shares worth $844,314 By Investing.com - Investing.com South Africa
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Disc medicine CEO sells shares worth $844,314 - Investing.com India
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $844,333.91 in Stock - MarketBeat
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Khara Rahul | Chief Legal Officer |
Jan 02 '25 |
Sale |
62.75 |
7,500 |
470,658 |
14,035 |
| Quisel John D | Chief Executive Officer |
Dec 30 '24 |
Option Exercise |
9.86 |
13,012 |
128,298 |
85,077 |
| Quisel John D | Chief Executive Officer |
Dec 31 '24 |
Option Exercise |
1.01 |
10,000 |
10,100 |
82,065 |
| Quisel John D | Chief Executive Officer |
Dec 30 '24 |
Sale |
61.95 |
13,012 |
806,058 |
72,065 |
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):